Cargando…
Liver enzyme delayed clearance in rat treated by CSF1 receptor specific antagonist Sotuletinib
Sotuletinib (BLZ945), a CSF1-R specific kinase inhibitor developed for the treatment of Amyotrophic Lateral Sclerosis, induced liver enzyme elevation in absence of hepatocellular lesions in preclinical rat and monkey studies. The monocytic cell family, including Kupffer cells, e.g., the liver-reside...
Autores principales: | Pognan, François, Buono, Chiara, Couttet, Philippe, Galarneau, Jean-René, Timsit, Yoav, Wolf, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637862/ https://www.ncbi.nlm.nih.gov/pubmed/36353522 http://dx.doi.org/10.1016/j.crtox.2022.100091 |
Ejemplares similares
-
ToxPoint: Health Disparities, COVID-19, and Owning Our Share
por: Pettit, Syril D
Publicado: (2020) -
ToxPoint: Copper Is the New Showstopper
por: Gupta, Govind, et al.
Publicado: (2022) -
Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?
por: Elmore, Susan A, et al.
Publicado: (2023) -
Effects of exposure to environmentally relevant concentrations of lead (Pb) on expression of stress and immune-related genes, and microRNAs in shorthorn sculpins (Myoxocephalus scorpius)
por: Jantawongsri, Khattapan, et al.
Publicado: (2022) -
Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)